Biotechnology leader Purbasa Patnaik joins Irish Construction Industry Awards panel

Purbasa Patnaik, Associate Director at Exelixis, will lend her considerable expertise from the biotechnology sector to the discerning judging panel of the Irish Construction Industry Awards 2025. Boasting over a decade in biologics formulation and drug product development, Ms Patnaik has consistently driven innovation and ensured rigorous execution in GMP manufacturing environments.

Her distinguished career spans pivotal roles at NGM Bio, Harpoon Therapeutics (Merck), and Eli Lilly, where she led critical drug product initiatives and secured regulatory approvals for novel oncology therapeutics. This background, characterised by meticulous planning, strategic oversight, and an unwavering commitment to best practice, offers a unique evaluative perspective beyond traditional industry boundaries.

Ms Patnaik's inclusion reinforces the Awards' commitment to a robust and diverse judging process. Her insights from a highly regulated and technologically advanced industry will be instrumental in identifying Irish construction projects and companies that demonstrate exceptional innovation, precision, and strategic foresight. As the sector prepares to recognise its leading lights, her discerning input is anticipated to elevate the ultimate selection, setting new benchmarks for industry excellence.

For a comprehensive list of all esteemed judges, visit the official awards website.